Position in AMGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,330,791
+$40,558 QoQ
Shares Held
3,675
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#1,506
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Perspectives, Inc holds $10,204,212 across 14 Drug Manufacturers - General names. AMGN ranks #3 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,220 | $3,326,680 | |
| 2 | JNJ |
Johnson & Johnson
|
8,020 | $2,036,839 | |
| 3 | AMGN |
Amgen Inc
This page
|
3,675 | $1,330,791 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
8,055 | $1,017,668 | |
| 5 | LLY |
ELI LILLY & Co
|
641 | $768,834 | |
| 6 | NVO |
Novo Nordisk A S
|
11,256 | $539,612 | |
| 7 | PFE |
Pfizer Inc
|
18,621 | $448,393 | |
| 8 | NVS |
Novartis AG
|
1,774 | $278,021 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,330,791 | 3,675 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,290,233 | 3,667 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,198,609 | 3,662 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,013,380 | 3,591 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $999,013 | 3,578 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,114,102 | 3,576 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $931,527 | 3,574 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,120,968 | 3,479 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,086,701 | 3,478 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $988,296 | 3,476 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,010,086 | 3,507 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $942,003 | 3,505 | Shares | Sole | 2024-01-10 | |
| 2023-06-30 | $772,185 | 3,478 | Shares | Sole | 2024-01-10 | |
| 2023-03-31 | $840,323 | 3,476 | Shares | Sole | 2024-01-10 | |
| 2022-12-31 | $911,886 | 3,472 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $782,138 | 3,470 | Shares | Sole | 2024-01-10 | |
| 2022-06-30 | $791,211 | 3,252 | Shares | Sole | 2024-01-10 | |
| 2022-03-31 | $785,673 | 3,249 | Shares | Sole | 2024-01-10 | |
| 2021-12-31 | $730,702 | 3,248 | Shares | Sole | 2024-01-10 | |
| 2021-09-30 | $690,261 | 3,246 | Shares | Sole | 2024-01-10 | |
| 2021-06-30 | $790,968 | 3,245 | Shares | Sole | 2024-01-10 | |
| 2021-03-31 | $3,244 | 807,130 | Shares | Sole | 2024-01-10 | |
| 2020-12-31 | $838,058 | 3,645 | Shares | Sole | 2024-01-10 | |
| 2020-09-30 | $913,196 | 3,593 | Shares | Sole | 2024-01-10 | |
| 2020-06-30 | $847,209 | 3,592 | Shares | Sole | 2024-01-10 | |
| 2020-03-31 | $727,800 | 3,590 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||